Single Center Comparison of Laparoscopic Cryoablation and CT-Guided Percutaneous Cryoablation for Renal Tumors

被引:32
|
作者
Derweesh, Ithaar H. [1 ]
Malcolm, John B. [1 ]
Diblasio, Christopher J. [1 ]
Giem, Andrew [1 ]
Rewcastle, John C. [3 ]
Wake, Robert W. [1 ]
Patterson, Anthony L. [1 ]
Gold, Robert [1 ,2 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Urol, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Sect Intervent Radiol, Dept Diagnost Radiol, Memphis, TN 38163 USA
[3] Univ Calgary, Fac Med, Dept Radiol, Calgary, AB, Canada
关键词
D O I
10.1089/end.2008.0196
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Purpose: Cryoablation has demonstrated therapeutic effectiveness for selected renal tumors. We compared our perioperative and short-term outcomes of laparoscopic (LAP) v percutaneous (PERC) renal cryoablation. Patients and Methods: Thirty-four patients (18 men/16 women) underwent a LAP and 26 patients (19 men/7 women) underwent a PERC procedure between September1998 and January 2007. LAP cryoablation was performed transperitoneally with ultrasonographic monitoring. PERC cryoablation was performed with CT guidance. Follow-up imaging was obtained at regular intervals. Results: Mean follow-up was 25 months. Average age (years) was 67.0 for the LAP and 69.7 for the PERC procedure (P = 0.307). Mean body mass index (kg/m(2)) was 29.8 for those undergoing LAP and 28.7 for those undergoing PERC procedures (P = 0.543). Mean tumor size (cm) was 2.9 for LAP patients and 3.1 for PERC patients (P = 0.432). Anterior tumors comprised 61.7% of LAP and 15.4% of PERC procedures (P < 0.001). Posterior tumors comprised 32.4% of LAP and 65.4% of PERC procedures (P = 0.01). Mean procedure time (minutes) was 165.7 for LAP and 106.6 for PERC procedures (P < 0.001). Hospital stay (days) was 2.6 for those undergoing LAP and 1.8 for those undergoing PERC procedures (P < 0.001). Both LAP patients (82.4%) and PERC patients (19.2%) needed postoperative narcotics (P < 0.001). Atelectasis developed in 70.6% of LAP patients and 34.6% of PERC patients (P = 0.005). Residual enhancement was seen in 11.5% of PERC patients and 2.9% of LAP patients (P = 0.192). Complications developed in 14.7% of LAP patients and 26.9% of PERC patients (P = 0.248). 1-year, 2-year, and 3-year disease-specific survival for the two groups was 100%. Tumor size > 4 cm and endophytic location were significantly associated with residual enhancement. Conclusions: LAP and PERC renal cryoablation have similar short-term outcomes. Significantly more anterior tumors were approached laparoscopically and significantly more posterior tumors were approached percutaneously. The PERC approach may offer advantages regarding hospital stay, narcotic need, and development of atelectasis. Longer-term data are needed to establish success of this approach.
引用
收藏
页码:2461 / 2467
页数:7
相关论文
共 50 条
  • [41] CT-guided percutaneous cryoablation of osteoid osteoma in children: an initial study
    Bin Wu
    Yue-Yong Xiao
    Xiao Zhang
    Lei Zhao
    John A. Carrino
    [J]. Skeletal Radiology, 2011, 40 : 1303 - 1310
  • [42] CT-Guided Percutaneous Cryoablation for Osteoid Osteoma: Initial Experience in Adults
    Coupal, Tyler M.
    Mallinson, Paul I.
    Munk, Peter L.
    Liu, David
    Clarkson, Paul
    Ouellette, Hugue
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (05) : 1136 - 1139
  • [43] Editorial Comment on: Complications of Laparoscopic and Percutaneous Renal Cryoablation in a Single Tertiary Referral Center
    Marberger, Michael
    [J]. EUROPEAN UROLOGY, 2010, 58 (01) : 147 - 148
  • [44] Percutaneous cryoablation with CT monitoring for the treatment of solid renal tumors
    [J]. Nature Clinical Practice Urology, 2007, 4 (7): : 350 - 350
  • [45] MRI- Versus CT-Guided Renal Tumor Cryoablation: Is There a Difference?
    Roberto Luigi Cazzato
    Pierre De Marini
    Theo Mayer
    Loïc Leclerc
    Ian Leonard-Lorant
    Danoob Dalili
    Julia Weiss
    Guillaume Koch
    Pierre-Alexis Autrusseau
    Julien Garnon
    Hervé Lang
    Afshin Gangi
    [J]. CardioVascular and Interventional Radiology, 2023, 46 : 901 - 910
  • [46] Comparison of Percutaneous and Laparoscopic Cryoablation for the Treatment of Solid Renal Masses
    Hinshaw, J. Louis
    Shadid, Anthony M.
    Nakada, Stephen Y.
    Hedican, Sean P.
    Winter, Thomas C., III
    Lee, Fred T., Jr.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (04) : 1159 - 1168
  • [47] MRI- Versus CT-Guided Renal Tumor Cryoablation: Is There a Difference?
    Cazzato, Roberto Luigi
    De Marini, Pierre
    Mayer, Theo
    Leclerc, Loic
    Leonard-Lorant, Ian
    Dalili, Danoob
    Weiss, Julia
    Koch, Guillaume
    Autrusseau, Pierre-Alexis
    Garnon, Julien
    Lang, Herve
    Gangi, Afshin
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2023, 46 (07) : 901 - 910
  • [48] The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center Report
    Pusceddu, Claudio
    Mascia, Luigi
    Ninniri, Chiara
    Ballicu, Nicola
    Zedda, Stefano
    Melis, Luca
    Deiana, Giulia
    Porcu, Alberto
    Fancellu, Alessandro
    [J]. CANCERS, 2022, 14 (12)
  • [49] CT-Guided Percutaneous Cryoablation for Lung Metastasis of Colorectal Cancer: A Case Series
    Wang, Fu-ming
    Luo, Rong
    Tian, Jin-ming
    Liu, Hang
    Yang, Ji-jin
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [50] CT-guided percutaneous cryoablation for palliative therapy of gastric cancer liver metastases
    Chang, Xu
    Wang, Yan
    Yu, Hai-Peng
    Zhang, Wei-Hao
    Yang, Xue-Ling
    Guo, Zhi
    [J]. CRYOBIOLOGY, 2018, 82 : 43 - 48